Here is a selection of this week's latest news from around the world
 |
 |
|
Eli Lilly to buy Loxo Oncology for $8 billionEli Lilly has announced its intention to buy pioneering cancer treatment development company Loxo Oncology in a deal worth approximately $8 billion. To read more follow this PharmaTimes link |
Pharma DTC spending outpaces rest of medical marketing, JAMA study findsSpending on most methods of medical marketing grew in the past two decades, but direct-to-consumer advertisements increased the fastest, a comprehensive analysis published Tuesday in JAMA found. To read more follow this BioPharmaDive link |
|
 |
 |
|
Sage soars on success of postpartum depression drugOne of Sage Therapeutics' pipeline assets scored an early victory in a late-stage study of postpartum depression patients, spurring a nearly 43% spike in the Cambridge, Massachusetts-based biotech's stock. To read more follow this BioPharmaDive link |
Caritas Neuro Solutions & Innvocept team upEdinburgh, Scotland-based mental health and neurology research company Caritas Neuro Solutions has signed a landmark partnership agreement with Mumbai, India-based digitally driven organisation Innvocept Solutions, enabling expansion of the company as a global player. To read more follow this PharmaTimes link |
|
 |
 |
|
Three men sentenced for supply of illicit medsThree people have been handed custodial sentences in England for their involvement in the illegal supply of potentially dangerous prescription-only medicines. To read more follow this PharmaTimes link |
Pain, depression and antipsychotics drum up enthusiasmSAN FRANCISCO — Therapies for central nervous system disorders competed for the limelight at the J.P. Morgan Healthcare Conference this week against the backdrop of big cancer deals — and held their own. To read more follow this BioPharmaDive link |